FOXO Technologies Plans to Launch Spin-Off of Epigenetics Unit

Author: Owen Jenkins Updated: 07-18-2025 07:17 AM

FOXO Technologies Moves Forward with Spin-Off Plans

FOXO Technologies Inc. (NYSE American: FOXO) has recently unveiled its intention to spin off its promising subsidiary, FOXO Labs, Inc., which specializes in epigenetics. This decision represents a significant step for the company as it aims to further enhance its innovation in epigenetic technology.

FOXO Labs: A Pioneer in Epigenetics

FOXO Labs has emerged as a leader in integrating epigenetic biomarkers into advanced consumer tools and underwriting protocols. With its patent for a groundbreaking machine learning model designed to analyze DNA epigenetic data, the subsidiary is paving the way for transformative health insights through non-invasive tests.

The Impact of Epigenetics on Health

Epigenetics enables us to gain crucial insights about health, lifestyle choices, and longevity—all from a simple saliva sample. This innovation not only spares individuals from invasive procedures like blood draws but also provides scientists with essential data for further research and development.

Revolutionizing Health Coaching

Mark White, the CEO of FOXO Labs, emphasized the company's commitment to harnessing its patented epigenetic technology along with an AI model to create a highly personalized health coaching experience. This AI coach will initially analyze existing wellness data from wearables, followed by deeper epigenetic analyses to devise customized action plans that can significantly enhance one’s health journey.

The Vision for Spinning Off FOXO Labs

Seamus Lagan, CEO of FOXO Technologies, discussed the strategic benefits of the spin-off. By allowing shareholders to directly own shares in FOXO Labs, Inc. while retaining partial ownership, FOXO believes it can simplify its business model and unlock greater value for its stakeholders.

FOXO Technologies and Its Subsidiaries

FOXO operates several subsidiary companies that offer diverse health-related services. One of these is Rennova Community Health, Inc., which manages a critical access hospital providing essential healthcare services. Another subsidiary, Myrtle Recovery Centers, Inc., ensures that individuals struggling with addiction receive proper inpatient and outpatient care.

Enhancing Human Lifespan Through Innovation

The mission of FOXO Labs, Inc. extends beyond traditional health methods. It is dedicated to improving individual lifespans through innovative technology and products. The focus on epigenetics signifies the company’s foresight in understanding the future of health management and wellness.

Contact Information for Further Inquiries

For more information, interested parties can reach out to Sebastien Sainsbury via email at ssainsbury@foxotechnologies.com or call at (561) 485-0151.

Frequently Asked Questions

What does FOXO Technologies specialize in?

FOXO Technologies focuses on advancing technologies in the health sector, particularly through epigenetics and biotechnology.

Why is FOXO spinning off FOXO Labs?

The spin-off is intended to create a more focused business model for both FOXO Technologies and FOXO Labs, allowing each entity to optimize its operations and strategy.

How does FOXO Labs utilize epigenetic technology?

FOXO Labs integrates epigenetic biomarkers into personalized health solutions, enabling non-invasive health assessments and insights.

What services does Rennova Community Health offer?

Rennova Community Health operates a hospital providing critical access care to local communities, ensuring essential medical services are available.

How can someone learn more about FOXO Technologies?

Visit FOXO Technologies' official website at www.foxotechnologies.com for more information.

About The Author

Hi there I'm 38-year-old author and financial consultant Owen Jenkins. Having worked in the financial sector for more than ten years, I am well-versed in the subtleties and complexity that mold our financial environment. Following a degree in finance, I worked in a number of financial institutions honing my abilities in market analysis, financial planning, and investment strategies.

My love is teaching others about investing and personal finance. My goal in writing many books and articles has been to demystify financial ideas and give readers the information they need to make wise financial decisions. I write with a direct, useful style that emphasizes doable suggestions for daily living.

Along with writing, I lead webinars and seminars where I impart knowledge on how to successfully negotiate the financial world. I also write for financial journals and show up as a guest expert on financial news programs a lot. Whether they are new to investing or want to improve their approach, my mission is to enable people to take charge of their financial futures.

Beyond work, I like to hike, play the guitar, and spend time with my family. I think that balance is crucial and want to encourage people to strike a balance between their financial aspirations and their hobbies. I want to help people succeed and achieve financial security through my work, so having a good influence.

Contact Owen Jenkins privately here. Or send an email with ATTN: Owen Jenkins as the subject to contact@investorshangout.com.

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.